Parkinson’s disease and cancer risk: a systematic review and meta-analysis A Bajaj, JA Driver, ES Schernhammer Cancer Causes & Control 21 (5), 697-707, 2010 | 289 | 2010 |
Shift work, chronotype, and melatonin rhythm in nurses P Razavi, EE Devore, A Bajaj, SW Lockley, MG Figueiro, V Ricchiuti, ... Cancer Epidemiology and Prevention Biomarkers 28 (7), 1177-1186, 2019 | 136 | 2019 |
Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with CKD A Bajaj, D Xie, E Cedillo-Couvert, J Charleston, J Chen, R Deo, ... American Journal of Kidney Diseases 73 (6), 827-836, 2019 | 67 | 2019 |
Lipoprotein (a) and risk of myocardial infarction and death in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort) A Bajaj, SM Damrauer, AH Anderson, D Xie, MJ Budoff, AS Go, J He, ... Arteriosclerosis, thrombosis, and vascular biology 37 (10), 1971-1978, 2017 | 48 | 2017 |
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia DJ Rader, E Maratos-Flier, A Nguyen, D Hom, M Ferriere, Y Li, J Kompa, ... The Journal of Clinical Endocrinology & Metabolism, 2021 | 40 | 2021 |
Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS sleep study A Bajaj, KL Stone, K Peters, N Parimi, E Barrett-Connor, D Bauer, ... The Journal of Clinical Endocrinology & Metabolism 99 (9), 3256-3262, 2014 | 39 | 2014 |
Validation of a light questionnaire with real-life photopic illuminance measurements: the Harvard Light Exposure Assessment questionnaire A Bajaj, B Rosner, SW Lockley, ES Schernhammer Cancer Epidemiology and Prevention Biomarkers 20 (7), 1341-1349, 2011 | 36 | 2011 |
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis P Hernandez, N Passi, T Modarressi, V Kulkarni, M Soni, F Burke, A Bajaj, ... Current Atherosclerosis Reports 23 (11), 1-13, 2021 | 33 | 2021 |
Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways A Bajaj, A Ihegword, C Qiu, AM Small, WQ Wei, L Bastarache, QP Feng, ... Kidney international 97 (5), 1032-1041, 2020 | 22 | 2020 |
Trends in mortality from stroke in Austria, 1980–2008 A Bajaj, ES Schernhammer, G Haidinger, T Waldhör Wiener Klinische Wochenschrift 122 (11), 346-353, 2010 | 22 | 2010 |
Advancements in the Treatment of Homozygous Familial Hypercholesterolemia A Bajaj, M Cuchel Journal of Atherosclerosis and Thrombosis 29 (8), 1125-1135, 2022 | 17 | 2022 |
A focused update to the 2019 NLA scientific statement on use of lipoprotein (a) in clinical practice ML Koschinsky, A Bajaj, MB Boffa, DL Dixon, KC Ferdinand, SS Gidding, ... Journal of Clinical Lipidology, 2024 | 14 | 2024 |
A systematic review of the natural history and biomarkers of primary lecithin: cholesterol acyltransferase deficiency C Vitali, A Bajaj, C Nguyen, J Schnall, J Chen, K Stylianou, DJ Rader, ... Journal of Lipid Research 63 (3), 2022 | 14 | 2022 |
Homozygous familial hypercholesterolemia: what treatments are on the horizon? A Bajaj, M Cuchel Current Opinion in Lipidology 31 (3), 119-124, 2020 | 13 | 2020 |
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study S Sheth, P Lee, A Bajaj, M Cuchel, J Hajj, DE Soffer, G Webb, E Hossain, ... Circulation: Cardiovascular Quality and Outcomes 14 (6), e007641, 2021 | 10 | 2021 |
APOL1 and Cardiovascular Disease: A Story in Evolution A Bajaj, K Susztak, SM Damrauer Arteriosclerosis, Thrombosis, and Vascular Biology 37 (9), 1587-1589, 2017 | 9 | 2017 |
Recent advances in the management and implementation of care for familial hypercholesterolaemia NSR Lan, A Bajaj, GF Watts, M Cuchel Pharmacological Research, 106857, 2023 | 7 | 2023 |
From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia? A Bajaj, M Cuchel European Heart Journal 43 (34), 3240-3242, 2022 | 7 | 2022 |
Use of Prophylactic Steroids to Mitigate Potential T-Cell Response in AAV8-Mediated hLDLR Gene Transfer in Subjects with Homozygous Familial Hypercholesterolemia M Cuchel, A Bajaj, R Carr, T Sikora, PB Duell, JC Tardif, JER van Lennep, ... MOLECULAR THERAPY 28 (4), 271-271, 2020 | 7 | 2020 |
Deep apolipoprotein proteomics to uncover mechanisms of coronary disease risk DJ Rader, A Bajaj, SA Khetarpal Journal of the American College of Cardiology 69 (7), 801-804, 2017 | 7 | 2017 |